文献速递肝病消化道肿瘤与早癌

微小RNA-21与Dicer在肝星状细胞活化及肝纤维化发生中并非必需

MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis.
PubMed 文献 · Hepatology · 2018-01-18

该研究在多种纤维化模型中观察到活化肝星状细胞(HSC)内微小RNA-21(miR-21)上调8至24倍,但反义抑制miR-21、两种独立生成的基因敲除小鼠删除miR-21均未改变HSC活化或毒性及胆汁性肝损伤模型中的肝纤维化;肝细胞癌与胆管癌中miR-21上调亦未被删除或抑制所逆转;HSC特异性删除Dicer对HSC活化与肝纤维化影响甚微。

要点

  • 活化HSC中miR-21较静息HSC上调8至24倍,但反义抑制未抑制鼠或人HSC活化。
  • 两种独立miR-21敲除小鼠及反义抑制均未改变毒性及胆汁性肝损伤模型的HSC活化或肝纤维化。
  • HSC特异性删除Dicer虽降低miRNA表达并改变部分基因表达,对HSC活化与肝纤维化影响甚微。

核心结论

  • 遗传学与药理学操作miR-21不抑制肝纤维化与肝癌的发生。
  • 抑制微小RNA合成不显著影响HSC表型与活化。

研究设计与样本

  • 研究在多种纤维化模型中检测活化HSC的miR-21表达,并使用反义抑制、两种独立生成的miR-21敲除小鼠及HSC特异性Dicer删除进行功能验证。

主要发现

  • 活化HSC中miR-21较静息HSC上调8至24倍,为多种纤维化模型中上调最强的微小RNA。
  • 反义抑制miR-21未抑制培养中或肝切片中鼠或人HSC的活化。
  • 两种独立生成的miR-21敲除小鼠或反义抑制均未改变毒性及胆汁性肝损伤模型的HSC活化或肝纤维化。
  • 损伤相关肝细胞癌与胆管癌中miR-21强烈上调,但删除或反义抑制miR-21未减少肝肿瘤发生。
  • HSC特异性删除Dicer降低HSC中微小RNA表达并改变部分基因表达,但对HSC活化与肝纤维化仅产生可忽略的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Fibrosis and cancer represent two major complications of chronic liver disease. MicroRNAs have been implicated in the development of fibrosis and cancer, thus constituting potential therapeutic targets. Here, we investigated the role of microRNA-21 (miR-21), a microRNA that has been implicated in the development of fibrosis in multiple organs and has also been suggested to act as an "oncomir." Accordingly, miR-21 was the microRNA that showed the strongest up-regulation in activated hepatic stellate cells (HSCs) in multiple models of fibrogenesis, with an 8-fold to 24-fold induction compared to quiescent HSCs. However, miR-21 antisense inhibition did not suppress the activation of murine or human HSCs in culture or in liver slices. Moreover, genetic deletion of miR-21 in two independently generated knockout mice or miR-21 antisense inhibition did not alter HSC activation or liver fibrosis in models of toxic and biliary liver injury. Despite a strong up-regulation of miR-21 in injury-associated hepatocellular carcinoma and in cholangiocarcinoma, miR-21 deletion or antisense inhibition did not reduce the development of liver tumors. As inhibition of the most up-regulated microRNA did not affect HSC activation, liver fibrosis, or fibrosis-associated liver cancer, we additionally tested the role of microRNAs in HSCs by HSC-specific Dicer deletion. Although Dicer deletion decreased microRNA expression in HSCs and altered the expression of select genes, it only exerted negligible effects on HSC activation and liver fibrosis. CONCLUSION: Genetic and pharmacologic manipulation of miR-21 does not inhibit the development of liver fibrosis and liver cancer. Moreover, suppression of microRNA synthesis does not significantly affect HSC phenotype and activation. (Hepatology 2018;67:2414-2429).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Caviglia JM, Yan J, Jang MK, et al. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology. 2018. PMID: 29091291. doi:10.1002/hep.29627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。